• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
NOVA1 acts as an oncogene in osteosarcoma.NOVA1在骨肉瘤中作为一种癌基因发挥作用。
Am J Transl Res. 2017 Oct 15;9(10):4450-4457. eCollection 2017.
2
NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression.NOVA1 通过调节 FOXO3a 表达在黑色素瘤中发挥癌基因作用。
J Cell Mol Med. 2018 May;22(5):2622-2630. doi: 10.1111/jcmm.13527. Epub 2018 Mar 2.
3
MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.微小 RNA-193a-5p 通过调节 NOVA1 在胶质母细胞瘤中发挥肿瘤抑制作用。
J Cell Biochem. 2019 Apr;120(4):6188-6197. doi: 10.1002/jcb.27906. Epub 2018 Oct 10.
4
RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA.RNA 结合蛋白 NOVA1 通过稳定 USP44 mRNA 促进急性 T 淋巴细胞白血病的进展。
Biochem Cell Biol. 2024 Feb 1;102(1):60-72. doi: 10.1139/bcb-2023-0092. Epub 2023 Oct 10.
5
LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.长链非编码RNA SNHG16通过靶向微小RNA-146a-5p促进骨肉瘤细胞的增殖和迁移。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):96-104. doi: 10.26355/eurrev_201901_16753.
6
NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.NOVA1 作为一种致癌 RNA 结合蛋白,调节人神经胶质瘤细胞中的胆固醇稳态。
Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2314695121. doi: 10.1073/pnas.2314695121. Epub 2024 Feb 28.
7
Oncogenic NOVA1 expression dysregulates alternative splicing in breast cancer.致癌性NOVA1表达失调会导致乳腺癌中的可变剪接异常。
bioRxiv. 2024 Jul 10:2024.07.08.602566. doi: 10.1101/2024.07.08.602566.
8
Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas.神经肿瘤腹侧抗原1(NOVA1)表达上调是成熟和不成熟T细胞及NK细胞淋巴瘤所特有的。
J Pathol Transl Med. 2016 Mar;50(2):104-12. doi: 10.4132/jptm.2016.02.08. Epub 2016 Feb 29.
9
NOVA1 expression is associated with clinicopathological characteristics and prognosis in patients with small cell lung cancer.NOVA1表达与小细胞肺癌患者的临床病理特征及预后相关。
Transl Cancer Res. 2020 Jul;9(7):4373-4382. doi: 10.21037/tcr-19-2806.
10
Expression of neuro-oncological ventral antigen-1 in small-cell lung cancer and its value in pathological diagnosis.神经肿瘤腹侧抗原-1在小细胞肺癌中的表达及其在病理诊断中的价值。
Transl Cancer Res. 2020 Feb;9(2):1144-1150. doi: 10.21037/tcr.2019.12.99.

引用本文的文献

1
Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification.与胶质瘤预后和免疫浸润相关的可变剪接事件的全景分析:数据分析和基础验证。
J Immunol Res. 2022 Jul 4;2022:2671891. doi: 10.1155/2022/2671891. eCollection 2022.
2
NOVA1 expression is associated with clinicopathological characteristics and prognosis in patients with small cell lung cancer.NOVA1表达与小细胞肺癌患者的临床病理特征及预后相关。
Transl Cancer Res. 2020 Jul;9(7):4373-4382. doi: 10.21037/tcr-19-2806.
3
MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.miR-146a 通过负向调控神经母细胞瘤性脑肿瘤抗原-1 发挥抑癌作用,抑制视网膜母细胞瘤的发生。
Kaohsiung J Med Sci. 2021 Apr;37(4):286-293. doi: 10.1002/kjm2.12337. Epub 2020 Dec 19.
4
LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.长链非编码 RNA MALAT1 通过调节 miR-3129-5p/Nova1 轴介导肝癌多柔比星耐药。
Mol Cell Biochem. 2021 Jan;476(1):279-292. doi: 10.1007/s11010-020-03904-6. Epub 2020 Sep 23.

本文引用的文献

1
miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease.微小RNA-513a-5p通过靶向人脱嘌呤/脱嘧啶内切核酸酶调节骨肉瘤的放射敏感性。
Oncotarget. 2016 Aug 2;9(39):25414-25426. doi: 10.18632/oncotarget.11003. eCollection 2018 May 22.
2
Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.NOVA1 抑制在胃癌微环境中的意义:与免疫细胞失调的关联。
Gastric Cancer. 2017 May;20(3):438-447. doi: 10.1007/s10120-016-0623-3. Epub 2016 Jun 18.
3
MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.微小RNA-224通过靶向Rac1提高骨肉瘤细胞对顺铂的敏感性。
J Cell Mol Med. 2016 Sep;20(9):1611-9. doi: 10.1111/jcmm.12852. Epub 2016 May 25.
4
MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.微小RNA-138通过靶向EZH2发挥肿瘤抑制作用并增强顺铂诱导的骨肉瘤细胞凋亡。
PLoS One. 2016 Mar 28;11(3):e0150026. doi: 10.1371/journal.pone.0150026. eCollection 2016.
5
MicroRNA-497 suppresses osteosarcoma tumor growth and .微小RNA-497抑制骨肉瘤肿瘤生长及…… (原文此处不完整)
Oncol Lett. 2016 Mar;11(3):2207-2212. doi: 10.3892/ol.2016.4162. Epub 2016 Jan 29.
6
Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas.神经肿瘤腹侧抗原1(NOVA1)表达上调是成熟和不成熟T细胞及NK细胞淋巴瘤所特有的。
J Pathol Transl Med. 2016 Mar;50(2):104-12. doi: 10.4132/jptm.2016.02.08. Epub 2016 Feb 29.
7
NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.miR-146b-5p在残余组织微环境中对NOVA1的抑制作用决定了胃癌切除术后隐匿性残留疾病的存在。
Oncotarget. 2016 Jan 19;7(3):2475-95. doi: 10.18632/oncotarget.6542.
8
MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.微小RNA-339是一种表观遗传调控靶点,通过靶向NOVA1参与人类胃癌发生。
FEBS Lett. 2015 Oct 7;589(20 Pt B):3205-11. doi: 10.1016/j.febslet.2015.09.009. Epub 2015 Sep 29.
9
MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.微小RNA-100通过靶向胰岛素样生长因子1受体抑制骨肉瘤细胞的增殖、迁移和侵袭并增强化疗敏感性。
Technol Cancer Res Treat. 2016 Oct;15(5):NP40-8. doi: 10.1177/1533034615601281. Epub 2015 Aug 25.
10
Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro.20种甾体糖苷对143B骨肉瘤细胞体外增殖及凋亡诱导作用的分析
Cell Prolif. 2015 Oct;48(5):600-10. doi: 10.1111/cpr.12208. Epub 2015 Aug 24.

NOVA1在骨肉瘤中作为一种癌基因发挥作用。

NOVA1 acts as an oncogene in osteosarcoma.

作者信息

Li Chengzhen, He Ying, Ma Haijing, Han Seongho

机构信息

Department of Family Medicine, College of Medicine, Dong-A UniversityBusan 604-714, Republic of Korea.

Department of Emergency, Heilongjiang Provincial HospitalHarbin 150000, Heilongjiang, China.

出版信息

Am J Transl Res. 2017 Oct 15;9(10):4450-4457. eCollection 2017.

PMID:29118907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5666054/
Abstract

Osteosarcoma is one of the most common bone tumors in young patients. NOVA1 (neuro-oncological ventral antigen 1) is a neuron-specific RNA binding-protein and belongs to the Nova family. Previous studies showed that NOVA1 played crucial roles in the development of several tumors. The objective of our study was to study the role of NOVA1 in the osteosarcoma. In our study, we showed that NOVA1 expression was upregulated in osteosarcoma cell lines and tissues. The expression of NOVA1 was upregulated in 22 (22/30; 73%) osteosarcoma cases compared to that in the adjacent tissues. Overexpression of NOVA1 promoted osteosarcoma cell viability, colony formation and invasion. Furthermore, knockdown of NOVA1 suppressed osteosarcoma cell viability, colony formation and invasion. These data suggested that NOVA1 acted as an oncogene in the development of osteosarcoma.

摘要

骨肉瘤是年轻患者中最常见的骨肿瘤之一。NOVA1(神经肿瘤腹侧抗原1)是一种神经元特异性RNA结合蛋白,属于Nova家族。先前的研究表明,NOVA1在几种肿瘤的发生发展中起关键作用。我们研究的目的是探讨NOVA1在骨肉瘤中的作用。在我们的研究中,我们发现NOVA1在骨肉瘤细胞系和组织中表达上调。与相邻组织相比,22例(22/30;73%)骨肉瘤病例中NOVA1表达上调。NOVA1的过表达促进了骨肉瘤细胞的活力、集落形成和侵袭。此外,敲低NOVA1可抑制骨肉瘤细胞的活力、集落形成和侵袭。这些数据表明,NOVA1在骨肉瘤的发生发展中起癌基因的作用。